24.51
24.51 (0.05%)
As of Jan 14, 2022
Aadi Bioscience, Inc. [AADI]
Source:
Company Overview
Aadi Bioscience, Inc. is a biopharmaceutical company focused on developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Our lead drug product, FYARRO , is a form of sirolimus bound to albumin. Sirolimus is a potent inhibitor of the mTOR biological pathway, the activation of which pathway can promote tumor growth.
Country | United States |
Headquarters | pacific palisades, california |
Phone Number | 424-473-8055 |
Industry | manufacturing |
CEO | Scott Giacobello |
Website | www.aadibio.com |